Skip to main content

Table 2 Angiographic and procedural characteristics

From: High platelet reactivity affects the clinical outcomes of patients undergoing percutaneous coronary intervention

  NPR on aspirin (n = 1240) HPR on aspirin (n = 91) P value NPR on clopidogrel (n = 891) HPR on clopidogrel (n = 437) P value
Multi-vessel disease, n (%) 517 (59.2) 41 (63.1) 0.601 363 (59.6) 194 (59.1) 0.889
Bifurcation lesion, n (%) 407 (32.8) 35 (38.5) 0.300 301 (33.8) 141 (32.3) 0.578
Thrombus-containing lesions, n (%) 113 (9.3) 5 (5.7) 0.336 77 (8.9) 41 (9.5) 0.683
IIb/IIIa Inhibitor, n (%) 122 (10.8) 7 (8.6) 0.709 96 (12.0) 33 (8.2) 0.048
DES used, n (%) 1240 (100) 91 (100) NS 891 (100) 437 (100) NS
Total implanted stent 2.78 ± 1.72 2.58 ± 1.61 0.287 2.81 ± 1.76 2.69 ± 1.62 0.235
Mean stent diameter, mm 3.08 ± 0.38 3.03 ± 0.34 0.313 3.08 ± 0.38 3.05 ± 0.39 0.155
Total stent length, mm 72.14 ± 48.69 65.06 ± 42.73 0.187 72.61 ± 49.14 69.77 ± 46.65 0.332
Complete revascularization, n (%) 823 (67.9) 59 (67.0) 0.906 598 (68.8) 281 (65.7) 0.256
Final TIMI grade 3, n (%) 1199 (98.2) 88 (98.9) NS 860 (98.3) 424 (98.1) 0.827
Heparin volume, units 7915.11 ± 2027.05 8085.00 ± 1945.01 0.503 7892.79 ± 2029.11 7999.97 ± 2012.82 0.421
  1. DES drug-eluting stent, TIMI thrombolysis in myocardial infarction, NPR normal platelet reactivity, HPR high platelet reactivity